Torrent Pharma ropes in Aman Mehta as Director on its board

Published On 2022-07-30 06:14 GMT   |   Update On 2022-07-30 06:14 GMT

New Delhi: Torrent Pharma on Friday said it has appointed Aman Mehta as Director on the company's board. Mehta, son of Torrent Pharma Chairman Samir Mehta, will take up the position with effect from August 1, 2022.Aman Mehta is a Bachelor of Economics from Boston University, Boston and an MBA from Columbia University, New York.During his tenure with Torrent, he has worked in both Power and...

Login or Register to read the full article

New Delhi: Torrent Pharma on Friday said it has appointed Aman Mehta as Director on the company's board. Mehta, son of Torrent Pharma Chairman Samir Mehta, will take up the position with effect from August 1, 2022.

Aman Mehta is a Bachelor of Economics from Boston University, Boston and an MBA from Columbia University, New York.

During his tenure with Torrent, he has worked in both Power and Pharma sectors. 

Prior to his elevation as Director, he was Executive Director at Torrent Pharma, heading the India Business along with Corporate HR. Further, he has led several organic growth initiatives that have started delivering market share expansion, with a focus on new product launches and market expansion. Aman is a key contributor in the evaluation of acquisition opportunities and driving the strategic direction of the India business.

He also serves as Director on the Board of Torrent Investments Private Limited and Saat Rasta Properties Private Limited.

Read also: Dr Reddys to sell Finast, Styptovit-E and 2 other brands to Torrent Pharma

Torrent Pharma is an Indian multinational pharmaceutical company headquartered in Ahmedabad, India. The company specializes in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC).

Read also: Torrent pharma successfully completes USFDA inspection for Levittown facility

Tags:    
Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News